News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
698,652 Results
Type
Article (39928)
Company Profile (271)
Press Release (658453)
Section
Business (205023)
Career Advice (2021)
Deals (35526)
Drug Delivery (96)
Drug Development (81204)
Employer Resources (172)
FDA (16184)
Job Trends (14899)
News (346319)
Policy (32607)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (4)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (5)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (6)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (6)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2565)
Accelerated approval (2)
Adcomms (20)
Allergies (80)
Alliances (49711)
ALS (81)
Alzheimer's disease (1351)
Antibody-drug conjugate (ADC) (110)
Approvals (16185)
Artificial intelligence (225)
Autoimmune disease (14)
Automation (14)
Bankruptcy (362)
Best Places to Work (11659)
BIOSECURE Act (19)
Biosimilars (101)
Biotechnology (190)
Bladder cancer (57)
Brain cancer (24)
Breast cancer (246)
Cancer (1961)
Cardiovascular disease (147)
Career advice (1686)
Career pathing (29)
CAR-T (140)
Cell therapy (394)
Cervical cancer (17)
Clinical research (65771)
Collaboration (764)
Compensation (446)
Complete response letters (18)
COVID-19 (2596)
CRISPR (35)
C-suite (204)
Cystic fibrosis (98)
Data (1897)
Decentralized trials (2)
Denatured (18)
Depression (36)
Diabetes (242)
Diagnostics (6347)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (109)
Drug pricing (97)
Drug shortages (25)
Duchenne muscular dystrophy (84)
Earnings (86244)
Editorial (31)
Employer branding (21)
Employer resources (146)
Events (112075)
Executive appointments (631)
FDA (17270)
Featured Employer (47)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (686)
Gene editing (96)
Generative AI (18)
Gene therapy (270)
GLP-1 (681)
Government (4391)
Grass and pollen (4)
Guidances (48)
Healthcare (18822)
Huntington's disease (23)
IgA nephropathy (21)
Immunology and inflammation (104)
Indications (26)
Infectious disease (2725)
Inflammatory bowel disease (135)
Inflation Reduction Act (10)
Influenza (46)
Intellectual property (83)
Interviews (312)
IPO (16517)
IRA (42)
Job creations (3663)
Job search strategy (1434)
Kidney cancer (9)
Labor market (34)
Layoffs (454)
Leadership (15)
Legal (7935)
Liver cancer (70)
Lung cancer (287)
Lymphoma (129)
Machine learning (2)
Management (58)
Manufacturing (265)
MASH (59)
Medical device (13324)
Medtech (13329)
Mergers & acquisitions (19471)
Metabolic disorders (621)
Multiple sclerosis (67)
NASH (16)
Neurodegenerative disease (76)
Neuropsychiatric disorders (24)
Neuroscience (1814)
NextGen: Class of 2025 (6547)
Non-profit (4487)
Northern California (2388)
Now hiring (37)
Obesity (336)
Opinion (205)
Ovarian cancer (71)
Pain (77)
Pancreatic cancer (77)
Parkinson's disease (130)
Partnered (18)
Patents (199)
Patient recruitment (93)
Peanut (46)
People (57378)
Pharmaceutical (67)
Pharmacy benefit managers (18)
Phase I (20503)
Phase II (28972)
Phase III (21573)
Pipeline (959)
Podcasts (47)
Policy (110)
Postmarket research (2564)
Preclinical (8682)
Press Release (64)
Prostate cancer (90)
Psychedelics (30)
Radiopharmaceuticals (243)
Rare diseases (350)
Real estate (5947)
Recruiting (65)
Regulatory (22176)
Reports (46)
Research institute (2323)
Resumes & cover letters (350)
Rett syndrome (3)
RNA editing (2)
RSV (37)
Schizophrenia (61)
Series A (122)
Series B (77)
Service/supplier (13)
Sickle cell disease (49)
Southern California (2068)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (28)
Startups (3624)
State (2)
Stomach cancer (12)
Supply chain (59)
The Weekly (26)
United States (20883)
Vaccines (654)
Venture capitalists (38)
Webinars (12)
Weight loss (225)
Women's health (33)
Worklife (15)
Date
Today (125)
Last 7 days (563)
Last 30 days (2689)
Last 365 days (33656)
2025 (7638)
2024 (35331)
2023 (40179)
2022 (51291)
2021 (55839)
2020 (54154)
2019 (46644)
2018 (35125)
2017 (32226)
2016 (31634)
2015 (37709)
2014 (31456)
2013 (26503)
2012 (28775)
2011 (29427)
2010 (27527)
Location
Africa (720)
Alabama (49)
Alaska (7)
Arizona (223)
Arkansas (13)
Asia (37895)
Australia (6208)
California (5457)
Canada (1853)
China (466)
Colorado (244)
Connecticut (256)
Delaware (123)
Europe (81305)
Florida (807)
Georgia (190)
Idaho (58)
Illinois (490)
India (24)
Indiana (289)
Iowa (9)
Japan (138)
Kansas (101)
Kentucky (23)
Louisiana (7)
Maine (60)
Maryland (821)
Massachusetts (4098)
Michigan (208)
Minnesota (366)
Mississippi (2)
Missouri (75)
Montana (27)
Nebraska (25)
Nevada (56)
New Hampshire (63)
New Jersey (1546)
New Mexico (28)
New York (1561)
North Carolina (909)
North Dakota (7)
Northern California (2388)
Ohio (192)
Oklahoma (14)
Oregon (34)
Pennsylvania (1239)
Puerto Rico (9)
Rhode Island (26)
South America (1097)
South Carolina (18)
South Dakota (1)
Southern California (2068)
Tennessee (92)
Texas (814)
Utah (163)
Virginia (128)
Washington D.C. (58)
Washington State (507)
West Virginia (3)
Wisconsin (48)
698,652 Results for "aura biosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Aura Biosciences to Participate in Upcoming Investor Conferences
February 26, 2025
·
1 min read
Press Releases
Aura Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights
March 24, 2025
·
12 min read
Genetown
Aura Biosciences to Participate in the Jefferies Global Healthcare Conference
Aura Biosciences, Inc. today announced that Elisabet de los Pinos, PhD, Chief Executive Officer, will present at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024, at 12:30 p.m. ET.
May 30, 2024
·
1 min read
Genetown
Aura Biosciences to Participate in Upcoming May 2024 Investor Conferences
Aura Biosciences, Inc. announced that Elisabet de los Pinos, PhD, Chief Executive Officer, will participate in the following upcoming investor conferences:
May 8, 2024
·
1 min read
Business
Aura Biosciences Reports First Quarter 2024 Financial Results and Business Highlights
Aura Biosciences, Inc. reported financial results for the first quarter ended March 31, 2024, and provided recent business highlights.
May 9, 2024
·
12 min read
Press Releases
Aura Biosciences Announces Additional Data from Ongoing Phase 1 Trial in Non-Muscle Invasive Bladder Cancer to be Presented as a Late-Breaking Abstract at the 40th Annual European Association of Urology Congress
March 4, 2025
·
10 min read
Press Releases
Aura Biosciences to Participate in the 7th Annual Evercore ISI HealthCONx Conference
November 26, 2024
·
1 min read
Genetown
Aura Biosciences to Participate in Upcoming Investor Conferences - February 26, 2024
Aura Biosciences Inc. today announced that Elisabet de los Pinos, PhD, Chief Executive Officer, will participate in the following upcoming investor conferences.
February 26, 2024
·
2 min read
Genetown
Aura Biosciences to Host Virtual KOL Event “Pioneering a New Standard of Care In Ocular Oncology” on May 29, 2024
Aura Biosciences, Inc., a clinical-stage biotechnology company developing precision immunotherapies to treat solid tumors designed to preserve the function of the organ with cancer, announced that it will host a virtual KOL event on Wednesday, May 29, 2024 at 2:00 PM ET.
May 23, 2024
·
7 min read
Business
Aura Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision immunotherapies to treat solid tumors to preserve the function of the afflicted organ with cancer, today reported financial results for the fourth quarter and year ended December 31, 2023, and provided recent business highlights.
March 27, 2024
·
13 min read
1 of 69,866
Next
